BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15099473)

  • 21. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
    Zhang SH; Cong WM; Xian ZH; Wu MC
    World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of methylation and loss of heterozygosity of RUNX3 gene in hepatocellular carcinoma and its clinical significance].
    Xiao WH; Liu WW
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):227-30. PubMed ID: 15099475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a 1-cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma.
    Bando K; Nagai H; Matsumoto S; Koyama M; Kawamura N; Onda M; Emi M
    Genes Chromosomes Cancer; 1999 Jul; 25(3):284-9. PubMed ID: 10379875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion mapping of chromosome 16q in hepatocellular carcinoma.
    Piao Z; Park C; Kim JJ; Kim H
    Br J Cancer; 1999 May; 80(5-6):850-4. PubMed ID: 10360665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error.
    Kawai H; Suda T; Aoyagi Y; Isokawa O; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Tsukada K; Mori S; Shimizu T; Suzuki Y; Abe Y; Takahashi T; Nomoto M; Asakura H
    Hepatology; 2000 Jun; 31(6):1246-50. PubMed ID: 10827149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inheritance instability of chromosome 6q in patients with gastric cancer].
    Chen P; Chu YL; Song TS; Lei L; Wang JS; Wang K; Ni L; Niu YY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):852-5. PubMed ID: 17243293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain.
    De Miglio MR; Muroni MR; Simile MM; Virdis P; Asara G; Frau M; Calvisi DF; Seddaiu MA; Pascale RM; Feo F
    Hepatology; 2001 May; 33(5):1110-7. PubMed ID: 11343238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse p53 gene aberration in hepatocellular carcinoma detected by dual-color fluorescence in situ hybridization.
    Kondo M; Marusawa H; Ueda Y; Katsurada A; Kawasome C; Takami S; Kinoshita M; Ikai I; Yamaoka Y; Chiba T
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1066-73. PubMed ID: 15304126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
    Momoi H; Okabe H; Kamikawa T; Satoh S; Ikai I; Yamamoto M; Nakagawara A; Shimahara Y; Yamaoka Y; Fukumoto M
    Clin Cancer Res; 2001 Sep; 7(9):2648-55. PubMed ID: 11555575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
    Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
    J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of some macrosatillite sites of chromosome 19 in primary gastric carcinoma with loss of heterozygosity].
    Jiang M; Xu L; Zhao Y; Fang HH; Chen ZH; Gao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):455-9. PubMed ID: 17611325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
    Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
    Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytogenetic and molecular genetic alterations on chromosome 4q in human hepatocellular carcinoma].
    Zhang HK; Wang HY; Xia JC
    Ai Zheng; 2008 Sep; 27(9):998-1005. PubMed ID: 18799044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma.
    Dong H; Cong WM; Xian ZH; Zhu ZZ
    Exp Mol Pathol; 2011 Oct; 91(2):578-83. PubMed ID: 21777579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
    Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
    Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma.
    Pineau P; Nagai H; Prigent S; Wei Y; Gyapay G; Weissenbach J; Tiollais P; Buendia MA; Dejean A
    Oncogene; 1999 May; 18(20):3127-34. PubMed ID: 10340384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.